alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2325 Introduced in House (IH)]

114th CONGRESS
  1st Session
                                H. R. 2325

   To amend title XVIII of the Social Security Act to provide for a 
  pharmaceutical and technology ombudsman under the Medicare program.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 14, 2015

 Mrs. Brooks of Indiana (for herself and Mr. Bilirakis) introduced the 
following bill; which was referred to the Committee on Ways and Means, 
 and in addition to the Committee on Energy and Commerce, for a period 
    to be subsequently determined by the Speaker, in each case for 
consideration of such provisions as fall within the jurisdiction of the 
                          committee concerned

_______________________________________________________________________

                                 A BILL

 
   To amend title XVIII of the Social Security Act to provide for a 
  pharmaceutical and technology ombudsman under the Medicare program.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. MEDICARE PHARMACEUTICAL AND TECHNOLOGY OMBUDSMAN.

    Section 1808(c) of the Social Security Act (42 U.S.C. 1395b-9(c)) 
is amended by adding at the end the following new paragraph:
            ``(4) Pharmaceutical and technology ombudsman.--Not later 
        than 12 months after the date of the enactment of this 
        paragraph, the Secretary shall provide for a pharmaceutical and 
        technology ombudsman within the Centers for Medicare & Medicaid 
        Services who shall receive and respond to complaints, 
        grievances, and requests that--
                    ``(A) are from entities that manufacture 
                pharmaceutical, biotechnology, medical device, or 
                diagnostic products that are covered or for which 
                coverage is being sought under this title; and
                    ``(B) regard coverage, coding, or payment under 
                this title for such products.''.
                                 <all>
```
# C_2021504EN.01003001.xml

| 14.12.2021 | EN | Official Journal of the European Union | C 504/30 |
| --- | --- | --- | --- |

14.12.2021

EN

Official Journal of the European Union

C 504/30

---

Non-opposition to a notified concentration

(Case M.10463 – SOCIÉTÉ GÉNÉRALE / HYUNDAI MOTOR COMPANY / JV)

(Text with EEA relevance)

(2021/C 504/04)

On 6 December 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10463. EUR-Lex is the online point of access to European Union law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10463. EUR-Lex is the online point of access to European Union law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
atec-ex101_6.htm



Exhibit 10.1

 

SECOND AMENDMENT TO THE

ALPHATEC HOLDINGS, INC. 

2007 EMPLOYEE STOCK PURCHASE PLAN

(As Amended and Restated Effective May 16, 2017)

This Second Amendment (this “Amendment”) to the Alphatec Holdings, Inc. 2007 Employee Stock Purchase Plan, as amended and restated effective May 16, 2017 (the “Plan”), is made and adopted by Alphatec Holdings, Inc. (the “Company”), a corporation organized under the laws of State of Delaware. Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Plan.


	
 
	
1.
	
Section 3.1 of the Plan is hereby amended to read as follows: 




“Number of Shares. Subject to Article VIII, the aggregate number of Shares that may be issued pursuant to rights granted under the Plan shall be 2,137,449 Shares. If any right granted under the Plan shall for any reason terminate without having been exercised, the Shares not purchased under such right shall again be available for issuance under the Plan.”


	
 
	
2.
	
This Amendment is effective as of June 16, 2021. 





	
 
	
3.
	
This Amendment shall be and is hereby incorporated in and forms a part of the Plan. All other terms and provisions of the Plan shall remain unchanged except as specifically modified herein. The Plan, as amended by this Amendment, is hereby ratified and confirmed. 




* * * * * * * *

I hereby certify that the foregoing Amendment was duly adopted by the Compensation Committee of the Board of Directors of the Company on February 17, 2021. 

 


	
ALPHATEC HOLDINGS, INC.

	
 
	
 

	
By:
	
 
	
/s/ Patrick S. Miles

	
Name:
	
 
	
Patrick S. Miles

	
Its:
	
 
	
President and Chief Executive Officer
# C_2021215EN.01000201.xml

| 7.6.2021 | EN | Official Journal of the European Union | C 215/2 |
| --- | --- | --- | --- |

7.6.2021

EN

Official Journal of the European Union

C 215/2

---

Non-opposition to a notified concentration

(Case M.10222 — CDPQ/Telefónica/FiBrasil JV)

(Text with EEA relevance)

(2021/C 215/02)

On 22 April 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10222. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10222. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
Order entered June 8, 2022

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-22-00313-CV

IN THE INTEREST OF B.J.E., A CHILD

On Appeal from the 86th Judicial District Court

Kaufman County, Texas

Trial Court Cause No. 101893-86

ORDER

The reporter’s record in this case has not been filed. By letter dated May 16, 

2022, we informed appellant the court reporter notified us that the reporter’s record 

had not been filed because appellant had not (1) requested the record; or (2) paid 

for or made arrangements to pay for the record. We directed appellant to provide 

the Court with written verification showing the reporter’s record had been 

requested and that appellant had paid for or made arrangements to pay for the 

record or had been found entitled to proceed without payment of costs. We 

cautioned appellant that failure to provide the required documentation within ten 

days might result in the appeal being ordered submitted without the reporter’s 
record. To date, appellant has not provided the Court with documentation showing 

he has requested the reporter’s record, nor otherwise corresponded with the Court 

regarding the status of the reporter’s record. Accordingly, we ORDER this appeal 

submitted without a reporter’s record. 

Appellant’s brief is due THIRTY DAYS from the date of this order. 

/s/ ROBERT D. BURNS, III

CHIEF JUSTICE
RODNEY J. SAMUEL II,

Petitioner,

v.

STATE OF FLORIDA,

Respondent.

___________________________/

IN THE DISTRICT COURT OF APPEAL

FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO 

FILE MOTION FOR REHEARING AND 

DISPOSITION THEREOF IF FILED

CASE NO. 1D16-2903

Opinion filed October 19, 2016.

Petition for Writ of Mandamus -- Original Jurisdiction.

Rodney J. Samuel II, pro se, Petitioner.

Pamela Jo Bondi, Attorney General, Tallahassee, for Respondent.

PER CURIAM.

The petition for writ of mandamus is denied. See Munn v. Fla. Parole Comm’n, 

807 So. 2d 733 (Fla. 1st DCA 2002). We encourage the circuit court to continue its 

efforts to expeditiously dispose of the motion pending below.

ROBERTS, C.J., MAKAR and BILBREY, JJ., CONCUR.
# C_2021497EN.01001401.xml

| 10.12.2021 | EN | Official Journal of the European Union | C 497/14 |
| --- | --- | --- | --- |

10.12.2021

EN

Official Journal of the European Union

C 497/14

---

Non-opposition to a notified concentration

(Case M.10495 – WP / AP / T-MOBILE NETHERLANDS)

(Text with EEA relevance)

(2021/C 497/03)

On 17 November 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10495. EUR-Lex is the online point of access to European Union law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10495. EUR-Lex is the online point of access to European Union law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
**Exhibit 23.1**

**Consent of Independent Registered Public Accounting Firm**

We consent to the incorporation byreference in Registration Statement number 333-138073 on Form S-3 and Registration Statement numbers 333-31751, 333-67265, 333-62618, 333-107462, 333-118041, 333-136406 and 333-144462 on Form S-8 of our report dated March 11, 2008, relating tothe consolidated financial statements of NMT Medical, Inc., for the year ended December 31, 2007 (which report expresses an unqualified opinion and includes an explanatory paragraph relating to the adoption of Financial Accounting StandardsBoard Interpretation No. 48 *Accounting for Uncertainty in Income Taxes an Interpretation of Financial Accounting Standards No . 109*) and our report dated March 11, 2008 relating to the effectiveness of NMT Medical Inc.’sinternal control over financial reporting, appearing in this Annual Report on Form 10-K of NMT Medical, Inc. for the year ended December 31, 2007. 

/s/ Deloitte & Touche LLP 

Boston, Massachusetts 

March 11, 2008
I 

114TH CONGRESS 

1ST SESSION H. R. 224 

To require the Surgeon General of the Public Health Service to submit 

to Congress an annual report on the effects of gun violence on public health. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 8, 2015 

Ms. KELLY of Illinois introduced the following bill; which was referred to the 

Committee on Energy and Commerce 

A BILL 

To require the Surgeon General of the Public Health Service 

to submit to Congress an annual report on the effects 

of gun violence on public health. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. REPORT ON EFFECTS OF GUN VIOLENCE ON 

4 PUBLIC HEALTH. 

5 Not later than one year after the date of the enact6 ment of this Act, and annually thereafter, the Surgeon 

7 General of the Public Health Service shall submit to Con8 gress a report on the effects on public health of gun vioVerDate Sep 11 2014 07:03 Jan 14, 2015 Jkt 049200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H224.IH H224

emcdonald on DSK67QTVN1PROD with BILLS
2 

•HR 224 IH

1 lence in the United States during the relevant period, and 

2 the status of actions taken to address such effects. 

Æ 


emcdonald on DSK67QTVN1PROD with BILLS
<TABLE> <S> <C>


<ARTICLE> 5




<S>                                                  <C>
<PERIOD-TYPE>                                             3-MOS
<FISCAL-YEAR-END>                                    DEC-31-2000
<PERIOD-START>                                       APR-01-2000
<PERIOD-END>                                         JUN-30-2000
<CASH>                                                   58,170
<SECURITIES>                                                  0
<RECEIVABLES>                                           400,738
<ALLOWANCES>                                             25,000
<INVENTORY>                                           2,449,806
<CURRENT-ASSETS>                                      3,282,153
<PP&E>                                                  270,494
<DEPRECIATION>                                           65,277
<TOTAL-ASSETS>                                        5,536,996
<CURRENT-LIABILITIES>                                 6,090,546
<BONDS>                                               1,528,167
<PREFERRED-MANDATORY>                                         0
<PREFERRED>                                           2,237,587
<COMMON>                                                  6,912
<OTHER-SE>                                           (4,366,573)
<TOTAL-LIABILITY-AND-EQUITY>                          5,536,996
<SALES>                                                 874,880
<TOTAL-REVENUES>                                        874,880
<CGS>                                                   456,105
<TOTAL-COSTS>                                           456,105
<OTHER-EXPENSES>                                      2,298,783
<LOSS-PROVISION>                                              0
<INTEREST-EXPENSE>                                      372,302
<INCOME-PRETAX>                                      (1,989,004)
<INCOME-TAX>                                                  0
<INCOME-CONTINUING>                                  (1,989,004)
<DISCONTINUED>                                          197,260
<EXTRAORDINARY>                                               0
<CHANGES>                                                     0
<NET-INCOME>                                         (1,791,744)
<EPS-BASIC>                                             (0.28)
<EPS-DILUTED>                                             (0.28)




</TABLE>
# C_2021483EN.01000401.xml

| 1.12.2021 | EN | Official Journal of the European Union | C 483/4 |
| --- | --- | --- | --- |

1.12.2021

EN

Official Journal of the European Union

C 483/4

---

Non-opposition to a notified concentration

(Case M.10500 – PSPIB / ADIC / LOCAL)

(Text with EEA relevance)

(2021/C 483/04)

On 8 November 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10500. EUR-Lex is the online point of access to European Union law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10500. EUR-Lex is the online point of access to European Union law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
ABIQUIU LAKELatitude: 36.269Longitude: -106.455Elevation: 6216

ABIQUIU LAKE

Courtesy NRCS - Go to Garita Peak Site Page...



Garita Peak

Courtesy NRCS - Go to Bateman Site Page...



Bateman

Courtesy NRCS - Go to Chamita Site Page...



Chamita

Courtesy NRCS - Go to Cumbres Trestle Site Page...



Cumbres Trestle

Courtesy NRCS - Go to Hopewell Site Page...



Hopewell
<TABLE> <S> <C>


<ARTICLE>                                            9
<MULTIPLIER>                                     1,000
       
<S>                                            <C>
<PERIOD-TYPE>                                  6-MOS
<FISCAL-YEAR-END>                              DEC-31-1997
<PERIOD-END>                                   JUN-30-1997
<CASH>                                           3,332
<INT-BEARING-DEPOSITS>                           6,571
<FED-FUNDS-SOLD>                                 1,000
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                          0
<INVESTMENTS-CARRYING>                         149,447
<INVESTMENTS-MARKET>                           148,872
<LOANS>                                        129,192
<ALLOWANCE>                                      1,060
<TOTAL-ASSETS>                                 299,989
<DEPOSITS>                                     225,385
<SHORT-TERM>                                    24,500
<LIABILITIES-OTHER>                              1,274
<LONG-TERM>                                      9,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           304
<OTHER-SE>                                      39,526
<TOTAL-LIABILITIES-AND-EQUITY>                 299,989
<INTEREST-LOAN>                                  4,495
<INTEREST-INVEST>                                5,457
<INTEREST-OTHER>                                     0
<INTEREST-TOTAL>                                 9,952
<INTEREST-DEPOSIT>                               5,069
<INTEREST-EXPENSE>                                 961
<INTEREST-INCOME-NET>                            3,922
<LOAN-LOSSES>                                      120
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                                  2,560
<INCOME-PRETAX>                                  1,500
<INCOME-PRE-EXTRAORDINARY>                         914
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       914
<EPS-PRIMARY>                                     0.36
<EPS-DILUTED>                                     0.35
<YIELD-ACTUAL>                                    2.70
<LOANS-NON>                                      2,487
<LOANS-PAST>                                       183
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                  2,489
<ALLOWANCE-OPEN>                                 1,090
<CHARGE-OFFS>                                      150
<RECOVERIES>                                         0
<ALLOWANCE-CLOSE>                                1,060
<ALLOWANCE-DOMESTIC>                             1,060
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                          1,060
        


</TABLE>
|  |  H.J. Helwerda, B.Sc., P.Eng., FEC, FGC (Hon), President D.J. Carsted, CD,  B.Sc., P.Geol.,ExecutiveVP, CTO C.P. Six, B.Sc., P.Eng., Senior VP, Unconventional N.T. Stewart, B.A.Sc., P.Eng., Senior VP, Canada S.W. Pennell, B.S., P.Eng., VP, Engineering, International A.A. Szabo, B.Sc., P.Eng., VP, Engineering, Canada B.F. Jose, M.Sc., P.Geoph., VP, Geoscience, International K.P. McDonald, B.Comm.,CA, CFO M.R. Van de Veen, QC, J.D., M.B.A., L.L.M.,                                     General Counsel, Corporate Secretary                                                |
|--|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Re: | Consent of Independent Petroleum Consultants |
|-----|----------------------------------------------|

| Sincerely,                                 |
|--------------------------------------------|
|                                       |
| SPROULE ASSOCIATES LIMITED                 |
|                                       |
|                                       |
| Original Signed by Nora T. Stewart, P.Eng. |
|                                       |
|                                       |
| Nora T. Stewart, P.Eng.                    |
| Senior Vice-President, Canada and Director |

----